Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Revenue by Segment

Financials in millions NGN. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017
Pharmaceuticals	7.18B	4.30B	2.07B	2.84B	2.64B
Animal Health	187.55M	184.26M	142.84M	75.09M	67.38M
Total	7.37B	4.49B	2.21B	2.92B	2.70B

Revenue by Geography

Financials in millions NGN. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017
Nigeria	7.37B	4.49B	2.21B	2.92B	2.70B
Total	7.37B	4.49B	2.21B	2.92B	2.70B

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error